The American Academy of Ophthalmology invited Dr. Novack to speak on drug delivery for glaucoma drugs at the Glaucoma sub-specialty day at the annual meeting in Las Vegas.
The Tear Film and Ocular Surface Society (TFOS) is sponsoring the Dry Eye Workshop II (DEWS II). Dr. Novack was a participant in the initial DEWS, published in 2007 www.tfosdewsreport.org. He presented the European regulatory perspective in TFOS i2 = INITIATING INNOVATION, the kick off for DEWS II in London in March 2015. Later that month, he was part of the organizing meeting of DEWS II in San Francisco, and he will chair the clinical trials sub-committee.
As he had every year since inception. Dr. Novack participated in the Glaucoma Research Foundation “New Horizons Forum” in February 2015. This year, he co-moderated an industry panel discussion on glaucoma pharmaceuticals. Here are two interviews from that event.